• Goldman Sachs crossed above 5% of Abivax’s capital and voting rights on September 28, 2026, through an off-market share acquisition.
• Its indirect holding reached 4,840,036 shares, representing 5.55% of capital and 5.47% of voting rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on October 16, 2026, and is solely responsible for the information contained therein.